JAK2 and essential thrombocythemia: In this study, statistically higher Hb and circulating granulocytes levels, lower EPO values and hypercellular BM on biopsy material in JAK2 V617F positive-compared to JAK2 negative ET patients, suggested a continuum in mutated patients between ET and PV phenotypes.